CAS 1322627-61-1

Ligelizumab

CAS: 1322627-61-1

A humanized high-affinity monoclonal anti-IgE antibody.

Ref: 3D-CLA1306

Ligelizumab

CAS: 1322627-61-1

Ligelizumab (QGE 031),High-affinity anti-IgE monoclonal antibody. Used in chronic spontaneous urticaria research.

Pureza: 95% - 98.8% (SDS-PAGE); 97.9% (SEC-HPLC)

Cor e Forma: Liquid

Peso molecular: 146.60 kDa

Ref: TM-T78289